Funding for this research was provided by:
National Institutes of Health (HL52141, 5K12HD047349)
Received: 10 October 2019
Accepted: 23 December 2019
First Online: 27 January 2020
: All animal experimental procedures were conducted in accordance with the animal care regulations of the National Institute of Health and were approved by Stanford University’s Administrative Panel on Laboratory Animal Care.
: Not applicable
: AUJ and DM-R hold patents related to P110 in neurodegenerative diseases. The other authors declare that they do not have competing interests.